Your browser doesn't support javascript.
loading
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
Pestaña-Fernández, Melani; Rubio-Rivas, Manuel; Tolosa-Vilella, Carles; Guillén-Del-Castillo, Alfredo; Colunga-Argüelles, Dolores; Argibay, Ana; Marí-Alfonso, Begoña; Marín-Ballvé, Adela; Pla-Salas, Xavier; Chamorro, Antonio-J; Castro-Salomó, Antoni; Madroñero-Vuelta, Ana Belén; Sánchez-García, María Esther; Sáez-Comet, Luis; González-Echávarri, Cristina; Ortego-Centeno, Norberto; Vargas-Hitos, José Antonio; Todolí-Parra, José Antonio; Trapiella-Martínez, Luis; Lledó, Gema María; Freire, Mayka; Fonollosa-Pla, Vicent; Simeón-Aznar, Carmen Pilar.
Afiliación
  • Pestaña-Fernández M; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rubio-Rivas M; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Tolosa-Vilella C; Department of Internal Medicine, Parc Taulí, Hospital Universitario, Sabadell, Barcelona, Spain.
  • Guillén-Del-Castillo A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Colunga-Argüelles D; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
  • Argibay A; Unit of Systemic Autoimmune Diseases and Thrombosis, Department of Internal Medicine, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain.
  • Marí-Alfonso B; Department of Internal Medicine, Parc Taulí, Hospital Universitario, Sabadell, Barcelona, Spain.
  • Marín-Ballvé A; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario Lozano Blesa, IIS Aragón, Zaragoza, Spain.
  • Pla-Salas X; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Consorci Hospitalari de Vic, Vic, Barcelona, Spain.
  • Chamorro AJ; Department of Internal Medicine, Hospital Clínico Universitario de Salamanca, Universidad de Salamanca-IBSAL, Salamanca, Spain.
  • Castro-Salomó A; Department of Internal Medicine. Hospital Universitario Sant Joan, Reus, Tarragona, Spain.
  • Madroñero-Vuelta AB; Department of Internal Medicine, Hospital General San Jorge, Huesca, Spain.
  • Sánchez-García ME; Department of Internal Medicine, Hospital Universitario Virgen de Valme, Sevilla, Spain.
  • Sáez-Comet L; Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • González-Echávarri C; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.
  • Ortego-Centeno N; Inst. Invest. Biosanitaria Ibs Granada, Department of Internal Medicine, Unit of Systemic Autoimmune Diseases, Department of Medicine, Facultad de Medicina, Hospital Universitario San Cecilio, Granada, Spain.
  • Vargas-Hitos JA; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Todolí-Parra JA; Department of Internal Medicine, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Trapiella-Martínez L; Unit of Systemic Autoimmune Diseases, Department of Internal Medicine, Hospital de Cabueñes, Gijón, Asturias, Spain.
  • Lledó GM; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain.
  • Freire M; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain.
  • Fonollosa-Pla V; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Simeón-Aznar CP; Unit of Autoimmune Diseases, Department of Internal Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Rheumatology (Oxford) ; 60(2): 872-880, 2021 02 01.
Article en En | MEDLINE | ID: mdl-32844220
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Úlcera Cutánea / Lesión Renal Aguda / Inhibidores de Fosfodiesterasa 5 / Antagonistas de los Receptores de Endotelina / Hipertensión Arterial Pulmonar Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Úlcera Cutánea / Lesión Renal Aguda / Inhibidores de Fosfodiesterasa 5 / Antagonistas de los Receptores de Endotelina / Hipertensión Arterial Pulmonar Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España